Basal VEGF-A and ACE Plasma Levels of Metastatic Colorectal Cancer Patients Have Prognostic Value for First-Line Treatment with Chemotherapy Plus Bevacizumab

Autor: M. José Ortiz-Morales, Marta Toledano-Fonseca, Rafael Mena-Osuna, M. Teresa Cano, Auxiliadora Gómez-España, Juan R. De la Haba-Rodríguez, Antonio Rodríguez-Ariza, Enrique Aranda

Publikováno v: Cancers; Volume 14; Issue 13; Pages: 3054
Cancers 14(13), 3054 (2022)
Helvia. Repositorio Institucional de la Universidad de Córdoba
instname

The identification of factors that respond to anti-angiogenic therapy would represent a significant advance in the therapeutic management of metastatic-colorectal-cancer (mCRC) patients. We previously reported the relevance of VEGF-A and some compone

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfd44df1a0b0a08ec917351a7af78401
https://www.mdpi.com/2072-6694/14/13/3054/pdf?version=1655972800